Approval · Notice of Compliance 24826 · 2020
ROFACT: Notice of Compliance 24826
Issued December 18, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24826
- Date
- December 18, 2020
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the design of the labels according to the new bausch health colours and to comply with plain language labelling guidelines
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ROFACT | Not yet assigned | — |